These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15587054)

  • 1. [Delirium in a 73-year-old man after many years of unwise use of betahistine].
    Hoenders HJ; Wilterdink J
    Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2338-41. PubMed ID: 15587054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of Ménière's disease: a randomized, double-blind, parallel group clinical study.
    Novotný M; Kostrica R
    Int Tinnitus J; 2002; 8(2):115-23. PubMed ID: 14763223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment costs of otogenic vertigo].
    Stratmann L; Heinen-Kammerer T; Motzkat-Gniss K; Holtmannspötter C; Rychlik R
    Med Klin (Munich); 2006 Nov; 101(11):886-90. PubMed ID: 17235475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence.
    Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE
    Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results.
    Casani AP; Guidetti G; Schoenhuber R;
    Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betahistine or Cinnarizine for treatment of Meniere's disease.
    Djelilovic-Vranic J; Alajbegovic A; Tiric-Campara M; Volic A; Sarajlic Z; Osmanagic E; Todorovic L; Beslagic O
    Med Arch; 2012; 66(6):396-8. PubMed ID: 23409520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease.
    Liu JL; Liu JG; Chen XB; Liu YH
    J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière's disease.
    Fraysse B; Bebear JP; Dubreuil C; Berges C; Dauman R
    Acta Otolaryngol Suppl; 1991; 490():1-10. PubMed ID: 1763646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing function after betahistine therapy in patients with Ménière's disease.
    Seyed Tootoonchi SJ; Ghiasi S; Shadara P; Samani SM; Fouladi DF
    Braz J Otorhinolaryngol; 2016; 82(5):500-6. PubMed ID: 26810620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable efficacy and tolerability between twice daily and three times daily betahistine for Ménière's disease.
    Ganança MM; Caovilla HH; Ganança FF
    Acta Otolaryngol; 2009 May; 129(5):487-92. PubMed ID: 18615332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betahistine: hallucinations?
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688903
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effects of betahistine on the function of equilibrium system].
    Kubiczkowa J
    Otolaryngol Pol; 1997; 51 Suppl 25():230-9. PubMed ID: 9757700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of a programmed release preparation of betahistine mesylate in the treatment of Ménière's disease (author's transl)].
    Pialoux P
    Ann Otolaryngol Chir Cervicofac; 1981; 98(9):483-6. PubMed ID: 7041769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betahistine metabolites, aminoethylpyridine, and hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo.
    Bertlich M; Ihler F; Sharaf K; Weiss BG; Strupp M; Canis M
    Int J Audiol; 2014 Oct; 53(10):753-9. PubMed ID: 25014609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betahistine: what's new on the agenda?
    Barak N
    Expert Opin Investig Drugs; 2008 May; 17(5):795-804. PubMed ID: 18447604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled clinical trial comparing the effect of betahistine hydrochloride and prochlorperazine maleate on patients with Meniére's disease.
    Aantaa E; Skinhoj A
    Ann Clin Res; 1976 Aug; 8(4):284-7. PubMed ID: 793500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of Meniere's vertigo with betahistine].
    Greiner GF; Conraux C; Collard M; Gentine A; Feblot P; Gillet B
    Rev Otoneuroophtalmol; 1975; 47(3):227-36. PubMed ID: 1219973
    [No Abstract]   [Full Text] [Related]  

  • 19. [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
    Popova NF; Chugunova MA; Kunel'skaia NL; Shagaev AS; Boĭko AN; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):77-81. PubMed ID: 21916160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of Meniere's disease using betahistine].
    Chüden HG
    Med Welt; 1978 Dec; 29(48):1901-3. PubMed ID: 713816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.